These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6877447)

  • 1. Pharmacokinetics of cimetidine in patients undergoing hemodialysis.
    Bjaeldager PA; Jensen JB; Nielsen LP; Larsen NE; Hvidberg EF
    Nephron; 1983; 34(3):159-63. PubMed ID: 6877447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of oral cimetidine in chronic renal failure and during haemodialysis.
    Bjaeldager PA; Jensen JB; Larsen NE; Hvidberg EF
    Br J Clin Pharmacol; 1980 Jun; 9(6):585-92. PubMed ID: 7387814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of cimetidine by peritoneal dialysis, hemodialysis, and charcoal hemoperfusion.
    Pizzella KM; Moore MC; Schultz RW; Walshe J; Schentag JJ
    Ther Drug Monit; 1980; 2(3):273-81. PubMed ID: 7222181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steady-state kinetics and dosage requirements of cimetidine in renal failure.
    Larsson R; Norlander B; Bodemar G; Walan A
    Clin Pharmacokinet; 1981; 6(4):316-25. PubMed ID: 7249490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.
    Larsson R; Erlanson P; Bodemar G; Walan A; Bertler A; Fransson L; Norlander B
    Br J Clin Pharmacol; 1982 Feb; 13(2):163-70. PubMed ID: 7059413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cimetidine and its sulphoxide metabolite during haemodialysis.
    Larsson R; Erlanson P; Bodemar G; Norlander B; Fransson L; Strouth L
    Eur J Clin Pharmacol; 1982; 21(4):325-30. PubMed ID: 7056278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of bioavailability and pharmacokinetics of cimetidine in subjects with normal and impaired renal function.
    Guay DR; Matzke GR; Bockbrader HN; Dancik J
    Clin Pharm; 1983; 2(2):157-62. PubMed ID: 6883944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral absorption of cimetidine and its clearance in patients with renal failure.
    Larsson R; Bodemar G; Norlander B
    Eur J Clin Pharmacol; 1979 Apr; 15(3):153-7. PubMed ID: 456399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rebound following hemodialysis of cimetidine and its metabolites.
    Ziemniak JA; Cersosimo RJ; Russo J; Moran DM; Kablitz C; Schentag JJ
    Am J Kidney Dis; 1984 May; 3(6):430-5. PubMed ID: 6720687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients.
    Somogyi A; Rohner HG; Gugler R
    Clin Pharmacokinet; 1980; 5(1):84-94. PubMed ID: 7363531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cimetidine pharmacokinetics.
    Abate MA; Hyneck ML; Cohen IA; Berardi RR
    Clin Pharm; 1982; 1(3):225-33. PubMed ID: 6764387
    [No Abstract]   [Full Text] [Related]  

  • 12. Cimetidine clearance during intermittent and chronic peritoneal dialysis.
    Hyneck ML; Murphy JF; Lipschutz DE
    Am J Hosp Pharm; 1981 Nov; 38(11):1760-2. PubMed ID: 7304634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered disposition and availability of cimetidine in liver cirrhotic patients.
    Gugler R; Müller-Liebenau B; Somogyi A
    Br J Clin Pharmacol; 1982 Sep; 14(3):421-30. PubMed ID: 7126415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
    Okolicsanyi L; Venuti M; Orlando R; Lirussi F; Nassuato G; Benvenuti C
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):482-7. PubMed ID: 7141756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of phenobarbital treatment on cimetidine kinetics.
    Somogyi A; Thielscher S; Gugler R
    Eur J Clin Pharmacol; 1981; 19(5):343-7. PubMed ID: 7238562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of cimetidine disposition in the aged.
    Ritschel WA
    Methods Find Exp Clin Pharmacol; 1983; 5(4):255-62. PubMed ID: 6888088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cimetidine disposition in patients undergoing continuous ambulatory peritoneal dialysis.
    Kogan FJ; Sampliner RE; Mayersohn M; Kazama RM; Perrier D; Jones W; Michael UF
    J Clin Pharmacol; 1983; 23(5-6):252-6. PubMed ID: 6875024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cimetidine dynamics after single intravenous doses.
    Pancorbo S; Bubrick MP; Chin TW; Miller KW; Onstad G
    Clin Pharmacol Ther; 1982 Jan; 31(1):83-8. PubMed ID: 7053310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics of cimetidine in ascitic cirrhotics].
    Albin H; Couzigou P; Vinçon G; Péhourcq F; Fleury B; Béraud C
    Gastroenterol Clin Biol; 1983 Mar; 7(3):251-5. PubMed ID: 6852412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.